Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 5

Results For "disorder"

620 News Found

Scientists develop rapid nanosensor to detect gut health biomarker for IBD and diabetes
R&D | June 02, 2026

Scientists develop rapid nanosensor to detect gut health biomarker for IBD and diabetes

Novel fluorescent nanosensor enables real-time detection of indole-3-propionic acid (IPA), paving the way for faster gut health screening, point-of-care diagnostics, and wearable monitoring devices


Samsung Bioepis launches Aflibercept biosimilar OPUVIZ across Europe
News | June 01, 2026

Samsung Bioepis launches Aflibercept biosimilar OPUVIZ across Europe

The aflibercept biosimilar, referencing Eylea, becomes the company’s fifth directly commercialized biosimilar in Europe, expanding access to ophthalmology treatments


International scientists say deuterium research could reshape medicine
R&D | June 01, 2026

International scientists say deuterium research could reshape medicine

The conference highlighted research suggesting that deuterium levels may influence key biological processes


Teen neuroscience researcher turns ADHD struggles into startup innovation
Medical Device | May 28, 2026

Teen neuroscience researcher turns ADHD struggles into startup innovation

Adya Anubhuti launches ADHD Copilot, an AI-powered platform designed to reduce stress and mental overload


Health ministry classifies Pregabalin under Schedule H1 to curb misuse
Policy | May 23, 2026

Health ministry classifies Pregabalin under Schedule H1 to curb misuse

New regulation mandates stricter prescription monitoring, sales record maintenance, and enhanced compliance across the pharmaceutical supply chain


ZIM Laboratories wins European regulatory milestone with anticoagulant approval in Italy
News | May 23, 2026

ZIM Laboratories wins European regulatory milestone with anticoagulant approval in Italy

The approval was granted by Agenzia Italiana del Farmaco


Lilly's retatrutide delivers 30% weight loss in Phase 3 TRIUMPH-1 trial
News | May 21, 2026

Lilly's retatrutide delivers 30% weight loss in Phase 3 TRIUMPH-1 trial

All three dose levels, 4 mg, 9 mg and 12 mg, successfully met the primary and key secondary endpoints in 80 weeks


Manipal Hospital launches ‘Oorja’ Support Group for celiac awareness in children
Hospitals | May 19, 2026

Manipal Hospital launches ‘Oorja’ Support Group for celiac awareness in children

Initiative focuses on early diagnosis, gut health awareness and long-term gluten-free care for children with celiac disease


Strand Life launches advanced proteomics capabilities
Biopharma | May 19, 2026

Strand Life launches advanced proteomics capabilities

The next-generation proteomics platform powered by Olink™ Explore HT enables simultaneous analysis of thousands of proteins from a single sample